首页> 外文期刊>Journal of Medical Genetics and Genomics >Relationship between H-RAS oncogene and uterine cancer
【24h】

Relationship between H-RAS oncogene and uterine cancer

机译:H-RAS癌基因与子宫癌的关系

获取原文
       

摘要

The current study is skillful to detect the mutations of the H-RAS oncogene in patient of uterine cancer. Thirty specimens of blood and tissue were collected for DNA extraction, H-RAS oncogene amplification and histopathology examination. The results, which revealed presence of mutations in H-RAS oncogene represented by homozygous wild type Leu/Leu was 20%, mutant translocation genotype Val/Val was 48%, mutant deletion genotype Val/Leu was 22% and heterozygous genotype Leu /Val was 10%. The histopathological results of this study reveal too many types of uterine cancer. The major types of uterine cancer that appear in this study represented by endometrial adenosquamous carcinoma are? associated with endometrial lieomyosarcoma, the other ?cases were represented as endometrial spheriodal cell carcinoma and as endometrial intra epithelial carcinoma.
机译:当前的研究熟练地检测了子宫癌患者中H-RAS癌基因的突变。收集了三十份血液和组织标本用于DNA提取,H-RAS癌基因扩增和组织病理学检查。结果表明,以纯合野生型Leu / Leu为代表的H-RAS癌基因中突变的存在率为20%,突变易位基因型Val / Val为48%,突变缺失基因型Val / Leu为22%,杂合基因型Leu / Val是10%。这项研究的组织病理学结果显示了太多类型的子宫癌。以子宫内膜腺鳞癌为代表的本研究中出现的主要子宫癌类型是?与子宫内膜平滑肌肉瘤相关的其他病例以子宫内膜球形细胞癌和子宫内膜内上皮癌为代表。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号